NCT00697086 - European Study of Dronedarone in Atrial Fibrillation | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions

Atrial Fibrillation

Interventions

DRUG

Dronedarone (SR33589)

DRUG

Placebo

Trial Locations (9)

Sanofi-aventis Administrative Office, Diegem

Sanofi-aventis Administrative Office, Prague

Sanofi-aventis Administrative Office, Paris

Sanofi-aventis Administrative Office, Milan

Sanofi-aventis Administrative Office, Gouda

Sanofi-aventis Administrative Office, Warsaw

Sanofi-aventis Administrative Office, Barcelona

Sanofi-aventis Administrative Office, Bromma

Sanofi-aventis Administrative Office, Geneva